Repare Therapeutics Inc. - Laporan Laba Rugi (TTM)

Repare Therapeutics Inc.
US ˙ NasdaqGS ˙ US7602731025

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Repare Therapeutics Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 0 0 1 1 8 8 8 121 132 137 167 56 51 98 69 67 53 1 0
Change (%) 122.96 92.69 47.93 785.78 3.18 5.10 1,362.13 9.39 4.00 21.57 -66.23 -9.15 91.38 -29.81 -3.14 -19.61 -97.99 -76.70
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 39 47 58 73 88 98 109 115 117 122 124 126 13 14 11 124 13 1 -15
Change (%) 20.31 24.12 26.37 20.06 11.32 11.52 5.39 1.54 4.60 1.89 1.18 -89.48 8.61 -25.82 1,065.59 -89.24 -94.93 -2,329.20
% of Revenue 28,722.22 15,499.00 9,983.79 8,528.67 1,155.97 1,247.17 1,323.38 95.39 88.54 89.05 74.64 223.64 25.89 14.69 15.53 186.88 25.02 63.19 -6,045.60
Gross Operating Profit -39 -46 -57 -72 -80 -90 -101 6 15 15 42 -70 38 83 58 -58 40 0 15
Change (%) 19.96 23.68 26.15 10.97 12.10 12.08 -105.51 171.97 -0.68 181.64 -264.66 -154.45 120.30 -30.50 -199.62 -169.38 -99.01 3,789.62
% of Revenue -28,622.22 -15,399.00 -9,883.79 -8,428.67 -1,055.97 -1,147.17 -1,223.38 4.61 11.46 10.95 25.36 -123.64 74.11 85.31 84.47 -86.88 74.98 36.81 6,145.60
SG&A 16 19 22 25 28 32 33 34 35 35 35 35 36 36 36 34 32 31 29
Change (%) 19.50 18.00 11.77 15.07 12.47 3.75 3.95 1.31 -0.72 2.25 -0.10 2.13 0.25 -1.11 -3.97 -6.39 -3.00 -7.32
% of Revenue 11,601.48 6,217.94 3,807.76 2,877.04 373.76 407.40 402.15 28.59 26.48 25.28 21.26 62.89 70.71 37.04 52.18 51.74 60.25 2,912.58 11,585.60
R&D 118 118 118 100 100 100
Change (%) 0.00 0.00 0.00 0.00
% of Revenue 230.70 120.54 171.75 187.04 9,321.99 40,010.00
OpEx 54 65 80 98 116 130 142 149 152 157 160 161 167 169 164 159 146 132 114
Change (%) 20.08 22.37 22.34 18.80 11.60 9.61 5.05 1.49 3.38 1.97 0.90 3.77 0.73 -2.44 -3.49 -8.26 -9.38 -13.70
% of Revenue 40,323.70 21,716.94 13,791.55 11,405.71 1,529.74 1,654.57 1,725.53 123.98 115.02 114.33 95.90 286.53 327.30 172.27 239.46 238.62 272.31 12,297.76 45,550.00
Operating Income -54 -65 -79 -97 -109 -122 -134 -29 -20 -20 7 -105 -116 -71 -96 -92 -92 -131 -114
Change (%) 19.82 22.04 22.15 12.02 12.19 9.90 -78.43 -31.50 -0.75 -134.75 -1,637.62 10.70 -39.15 35.43 -3.73 -0.08 42.04 -13.19
% of Revenue -40,223.70 -21,616.94 -13,691.55 -11,305.71 -1,429.74 -1,554.57 -1,625.53 -23.98 -15.02 -14.33 4.10 -186.53 -227.30 -72.27 -139.46 -138.62 -172.31 -12,197.76 -45,450.00
Interest Expense
Change (%)
% of Revenue
Net Income -53 -62 -77 -94 -107 -120 -132 -26 -29 -29 -3 -97 -94 -46 -69 -84 -85 -128 -110
Change (%) 16.50 23.31 22.34 13.88 12.48 9.80 -80.55 13.12 0.63 -89.45 3,059.01 -3.72 -51.28 49.96 22.66 0.76 51.02 -14.10
% of Revenue -39,568.15 -20,675.42 -13,231.03 -10,941.84 -1,406.68 -1,533.38 -1,601.94 -21.31 -22.03 -21.32 -1.85 -173.09 -183.44 -46.69 -99.76 -126.34 -158.37 -11,919.29 -43,945.60

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista